KIM, HONG JIN,김홍진,LEE, NA GYONG,이나경,CHO, YANG JE,조양제,JANG, JIN WOOK,장진욱,KIM, HYOUNG JIN,김형진,KIM, KWANG SUNG,김광성
申请号：
KR1020130079935
公开号：
KR1020130083426A
申请日:
2013.07.08
申请国别(地区):
KR
年份:
2013
代理人:
摘要：
PURPOSE: A uterine cervix cancer vaccine is provided to show excellent immunity in Th1 type immune response (cellular immunity) and Th2 type immune response (humoral immunity) and to be used as an excellent vaccine. CONSTITUTION: Saccharomyces cerevisiae (deposit number : KCCM11036P) is transformed by a nucleic acid sequence of L1 virus-like particle (VLP) of human papilloma virus (HPV) type 16. The strain is transformed by a nucleic acid sequence of L1 VLPs of HPV type 18. A uterine cervix cancer vaccine pharmaceutical composition contains: L1 VLP of HPV type 16, L1 VLP of HPV type 18, or a combination thereof； deacylation non-toxic lipopolysaccharides (LOS)； and a pharmaceutically acceptable carrier.본 발명은 인간 자궁경부암 백신 약제학적 조성물 및 인간 자궁경부암 예방 방법에 관한 것이다.
